FIELD: medicine, veterinary science.
SUBSTANCE: invention concerns veterinary. There is described a method of treating diabetes in a mammal with the use of peptide Arg-Pro-Gly-Pro dissolved in such proportion that the amount of the introduced peptide is 1 mg/kg of body weight. Said substance is introduced 3 times intranasally.
EFFECT: invention allows faster recovery, lower toxic effects without deterioration of clinical effectiveness.
2 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
USING TETRAPEPTIDE Pro-Gly-Pro-Val AS AGENT FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, METHOD FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LIPID STORAGE DISEASE AND METHOD FOR PREPARING IT | 2013 |
|
RU2537133C2 |
METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
METHOD FOR PREVENTION AND TREATMENT OF CARBOHYDRATE AND LIPID METABOLISM DISORDER IN METABOLIC SYNDROME AND ENCEPHALOPATHY, USE OF TETRAPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF SUCH DISORDERS | 2012 |
|
RU2480234C1 |
METHOD FOR PREVENTING HYPERCOAGULATION IN ANIMALS UNDER STRESS | 2019 |
|
RU2741948C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA | 2019 |
|
RU2709503C1 |
METHOD FOR PREVENTING AND TREATING DIABETES MELLITUS COMPLICATIONS ASSOCIATED WITH DEVELOPING DEGENERATIVE PROCESSES IN NERVE TISSUE, PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE THERAPY OF SUCH COMPLICATIONS, AND METHOD FOR PREPARING IT | 2012 |
|
RU2484844C1 |
APPLICATION OF PRO-GLY-PRO TRIPEPTIDE AS PREPARATION FOR TREATING AND PREVENTING DIABETES, METHOD FOR PREVENTING AND TREATING DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DIABETES | 2004 |
|
RU2252778C1 |
Authors
Dates
2010-11-20—Published
2009-10-23—Filed